• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物测定指导下从明日叶(Angelica keiskei Koidz.)根部分离和鉴定抗血小板活性化合物。

Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidz.).

作者信息

Son Dong Ju, Park Ye Oak, Yu Chengguang, Lee Sung Eun, Park Young Hyun

机构信息

a School of Applied Bioscience, Kyungpook National University , Daegu 702-701 , South Korea.

出版信息

Nat Prod Res. 2014;28(24):2312-6. doi: 10.1080/14786419.2014.931389. Epub 2014 Jul 14.

DOI:10.1080/14786419.2014.931389
PMID:25019280
Abstract

Platelet aggregation is fundamental to a wide range of physiological and pathological processes, including the induction of thrombosis and arteriosclerosis. Anti-platelet activity of a crude methanol extract and solvent fractions of Ashitaba roots (Angelica keiskei Koidz.) was evaluated using a turbidimetric method using washed rabbit platelets. We identified the anti-platelet activities of two chalcones, 4-hydroxyderricin and xanthoangelol, isolated from the ethyl acetate-soluble fraction of Ashitaba roots by using a bioassay-guided isolation method. 4-Hydroxyderricin and xanthoangelol effectively inhibited platelet aggregation induced by collagen (IC50 of 41.9 and 35.9 μM, respectively), platelet-activating factor (IC50 of 46.1 and 42.3 μM, respectively) and phorbol 12-myristate 13-acetate (IC50 of 16.5 and 45.9 μM, respectively). These compounds did not inhibit thrombin-induced platelet aggregation (IC50 of>80 μM). The results suggest that the chalcones 4-hydroxyderricin and xanthoangelol may be potent anti-thrombotic components of A. keiskei Koidz.

摘要

血小板聚集是广泛的生理和病理过程的基础,包括血栓形成和动脉硬化的诱导。使用洗涤过的兔血小板,通过比浊法评估明日叶根(当归明日叶)粗甲醇提取物和溶剂馏分的抗血小板活性。我们采用生物测定引导的分离方法,从明日叶根的乙酸乙酯可溶部分中鉴定出两种查耳酮——4-羟基德里辛和黄当归醇的抗血小板活性。4-羟基德里辛和黄当归醇分别有效抑制胶原蛋白诱导的血小板聚集(IC50分别为41.9和35.9 μM)、血小板活化因子诱导的血小板聚集(IC50分别为46.1和42.3 μM)以及佛波醇12-肉豆蔻酸酯13-乙酸酯诱导的血小板聚集(IC50分别为16.5和45.9 μM)。这些化合物不抑制凝血酶诱导的血小板聚集(IC50>80 μM)。结果表明,查耳酮4-羟基德里辛和黄当归醇可能是明日叶的有效抗血栓成分。

相似文献

1
Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidz.).生物测定指导下从明日叶(Angelica keiskei Koidz.)根部分离和鉴定抗血小板活性化合物。
Nat Prod Res. 2014;28(24):2312-6. doi: 10.1080/14786419.2014.931389. Epub 2014 Jul 14.
2
Anti-platelet effects of chalcones from Koidzumi (Ashitaba) .小泉(明日叶)中查耳酮的抗血小板作用。
Pharmazie. 2016 Nov 2;71(11):651-654. doi: 10.1691/ph.2016.6678.
3
Six new chalcones from Angelica keiskei inducing adiponectin production in 3T3-L1 adipocytes.从明日叶中分离出的六种新型查尔酮可诱导3T3-L1脂肪细胞产生脂联素。
Biosci Biotechnol Biochem. 2012;76(5):961-6. doi: 10.1271/bbb.110976. Epub 2012 May 7.
4
Absorption and metabolism of 4-hydroxyderricin and xanthoangelol after oral administration of Angelica keiskei (Ashitaba) extract in mice.口服当归属植物提取物后 4-羟基当归素和黄当归醇的吸收和代谢。
Arch Biochem Biophys. 2012 May;521(1-2):71-6. doi: 10.1016/j.abb.2012.03.013. Epub 2012 Mar 20.
5
Inhibitory effects of 4-hydroxyderricin and xanthoangelol on lipopolysaccharide-induced inflammatory responses in RAW264 macrophages.4-羟基血根碱和黄烷酮醇对脂多糖诱导的 RAW264 巨噬细胞炎症反应的抑制作用。
J Agric Food Chem. 2014 Jan 15;62(2):462-7. doi: 10.1021/jf404175t. Epub 2014 Jan 6.
6
Antitumor and antimetastatic actions of xanthoangelol and 4-hydroxyderricin isolated from Angelica keiskei roots through the inhibited activation and differentiation of M2 macrophages.从当归根中分离得到的黄当归醇和 4-羟基二氢血根碱通过抑制 M2 巨噬细胞的激活和分化发挥抗肿瘤和抗转移作用。
Phytomedicine. 2015 Jul 15;22(7-8):759-67. doi: 10.1016/j.phymed.2015.05.005. Epub 2015 May 27.
7
Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol.明日叶根的抗肿瘤和抗转移活性,第1部分:活性物质黄当归醇的分离
Int J Cancer. 2003 Sep 1;106(3):429-37. doi: 10.1002/ijc.11256.
8
PTP1B inhibitors from stems of Angelica keiskei (Ashitaba).明日叶茎部的蛋白酪氨酸磷酸酶1B抑制剂
Bioorg Med Chem Lett. 2015;25(10):2028-32. doi: 10.1016/j.bmcl.2015.04.003. Epub 2015 Apr 4.
9
Integration of Biochemometrics and Molecular Networking to Identify Antimicrobials in Angelica keiskei.整合生物化学计量学与分子网络以鉴定明日叶中的抗菌物质。
Planta Med. 2018 Jul;84(9-10):721-728. doi: 10.1055/a-0590-5223. Epub 2018 Mar 23.
10
4-Hydroxyderricin and xanthoangelol from Ashitaba (Angelica keiskei) suppress differentiation of preadiopocytes to adipocytes via AMPK and MAPK pathways.从明日叶(Angelica keiskei)中提取的 4-羟基当归素和黄当归醇通过 AMPK 和 MAPK 途径抑制前脂肪细胞向脂肪细胞分化。
Mol Nutr Food Res. 2013 Oct;57(10):1729-40. doi: 10.1002/mnfr.201300020. Epub 2013 May 16.

引用本文的文献

1
Pharmacophore Modeling and Binding Affinity of Secondary Metabolites from to HMG Co-A Reductase.从 到 HMG Co-A 还原酶的次生代谢产物的药效团建模和结合亲和力。
Molecules. 2024 Jun 23;29(13):2983. doi: 10.3390/molecules29132983.
2
The pharmacology activities of Koidzumi and its efficacy and safety in humans.小泉的药理活性及其在人体中的疗效和安全性。
Heliyon. 2024 Jan 13;10(2):e24119. doi: 10.1016/j.heliyon.2024.e24119. eCollection 2024 Jan 30.
3
Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities.
明日叶,一种具有多种生物活性成分和生物活性的新兴药草。
Arch Pharm Res. 2017 Jun;40(6):655-675. doi: 10.1007/s12272-017-0892-3. Epub 2017 Apr 24.